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Engagement of the TCR can lead to a variety of conse-
quences, such as cell proliferation, clonal anergy (1-3),
and programmed cell death (4, 5). These consequences are
critical for clonal selection, providing responses to nonself
while preserving self-tolerance. Thus, the mechanisms that
determine which of these responses will result are an essen-
tial component of self-nonself discrimination by T cells. In
this report, we show that antiTCR/CD3 stimulation in the
absence of costimulatoryy signals leads to cell death of Thl
clones, and that IFN-y plays a critical role in this process.
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Summary
We have used anti-T cell monoclonal antibodies (mAbs) as mimic ligands to study the effects
of T cell receptor (TCR) ligation of cloned T helper type 1 cells in the presence or absence
of accessory cells. Our results demonstrate that ligation of the TCR in the absence of accessory
cells rapidly induces cell death. Cell death can be prevented by addition of spleen adherent cells,
leading to strong clonal expansion. Induced cell death is inhibited by rclosporin A and by
anti-interferon y (IFN-y), and is restored by adding exogenous recombinant IFN-y to ryclosporin
A-treated cells. These results demonstrate that IFN-y plays a critical role in cell death induced
by anti TCR mAbs in the absence of costimulatory cells. We propose that induced cell death
of active effector T cells provides a third mechanism oftolerance in addition to intrathymic deletion
of developing autoreactive T cells and peripheral inactivation of mature, naive T cells.
Mice, Antibodies, and Cells.
￿
BALB/cByJ mice were purchased
from TheJackson laboratory (Bar Harbor, ME). Adult mice of >6
wk of age were used. mAbs specific for Thy-1 (Y19) and CD3 e
chain (YCD3-1) were prepared in this lab and have been described
previously (6, 7). mAbs specific for all TCR-tx//3 (H57-597) were
kindly provided by Dr. Ralph Kubo (8) (National Jewish Center
for Immunology and Respiratory Medicine, Denver, CO). mAbs
to 11,2 (S4B6.34) (9) and IFN-'y (XMG 1.2) (10) were kindly
provided by Dr. Tim Mosmann (University of Alberta, Edmonton,
Canada). All antibodies were purified from hybridoma superna-
tant through a protein G-Sepharose column (Pharmacia Fine Chem-
icals, Piscataway, NJ).
The cloned Thl cells 5.9 were prepared in this laboratory and
have been described (11). This clone was derived from BALB/cByJ
mice and recognizes OVA presented by I-Ad.
Proliferation Response of T Cell Clones to 11,2 in the Presence of
CrosslinkedAntiTCR/CD3 mAb mAbs were diluted in PBS and
incubated in 96-well flat-bottomed tissue culture plates (40 jiI/well)
for 2 h at 37°C. At the end of the incubation, the plates were
washed threetimes with Click's Eagle's Hank's amino acid (EHAA;
Irvine Scientific, Santa Ana, CA) medium containing 5% FCS.
Cloned T cells (2 x 10'/well) were cultured in the presence of
murine rIL2 (50 U/ml) for 42 h. Thesecultures were pulsed with
1 PCi [3H]TdR for an additional 6 h and [3H]TdR incorporation
was determined.
Evaluation ofCellDeath by Trypan BlueExclusionandbyFlow Cytom-
etry with Propidium Iodide-Stained Cells. T cell clones were incubated
in 96-well plates coated with anti-T cell mAb (5,ug/ml) or medium
controls for 16-20 h. The cells were harvested by pipetting and
diluted 1:2 with 0.1% trypan blue in PBS. The live and dead cells
were counted in a hemocytometer. The percentage of specific cell
death was calculated according to the following formula. Percent
specific cell death = 100 x (percent dead cells in sample - percent
dead cells in medium)/(100% - percent dead cells in medium).
For FACS analysis of cell death, T cell clones were suspended
in Click's EHAA medium containing 5% FCS at a density of 3
x 105/ml. This cell suspension was incubated in 24-well tissue
culture plates (1 ml/well) that were precoated with anti-T cell mAb
(5 hg/ml) at 37°C in humidified air containing 5%C02. Cells
were harvested after a 16-h incubation, washed once with PBS,
and suspended in PBS containing propidium iodide (2 jig/ml). The
fluorescence intensity was determined with a FACS 440 (Becton
Dickinson & Co., Mountain View, CA).
Results and Discussions
Crosslinking the TCR on Th1 Clones in the Absence ofCo-
stimulatory Signals Induces Cell Death. Proliferation of clone
5 .9 to anti-CD3/TCR mAbs requires both crosslinking
antibodies and costimulatory signals from accessory cells.
1735
￿
J. Exp. Med. ® The Rockefeller University Press " 0022-1007/90/12/1735/05 $2.00
Volume 172 December 1990 1735-17390
L
d
d
U
U
.V
d a
to
N
U
C
N
U
N
0)
w
O
O
anti-Thyt anti-CD3 anti-TCR
Antibodies
Figure 1.
￿
Induction ofcell death of 5.9 cells by anti-T cell mAbs. Data
shown are percentages of specific cell death as determined by trypan blue
exclusion of clone 5.9 cells 24 h after stimulation in plates coated with
5 Wg/ml ofmAb. Similar data were obtained when T cells were stimulated
with 0.05 ug/ml of mAb.
Plastic-adsorbed antiTCR and anti-CD3 mAb do not induce
proliferation in the absence of accessory cells (data not shown).
However, these mAbs do induce death of clone 5.9 cells as
determined by trypan blue dye exclusion after 16 h of culture
(Fig. 1), fluorescence-activated cell sorter (FACS is a regis-
tered trademark of Becton Dickinson and Company) staining
with propidium iodide (Fig. 2), and loss of responsiveness
to 11r2 (Fig. 3). As shown in Fig. 1, -65-70% of specific
cell death was recorded by trypan blue dye exclusion. When
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Figure 3.
￿
Inhibition of proliferation to 11:.2 (50 U/ml) of 5 .9 cells by
various amounts of plate-bound antiTCR/CD3 mAb. Data shown are
means of duplicates from a 48-h assay.
5 .9 cells were stained with propidium iodide, anti-CD3
mAb-treated cultures contained a significant proportion of
brightly stained cells(ti18%), while antiThy-1-or medium-
treated cells contained <7% of brightly stained cells (Fig.
2) . Furthermore, there is a marked reduction in the viable
cells from anti-CD3-coated wells as determined by forward
scatter, suggesting that some dead cells do not stain with
propidium iodide.
Another manifestation of cell death is the loss of respon-
siveness to 11x2 (Fig. 3). T cells cultured with medium or
Figure 2.
￿
Analysis ofcell death by flow cytometry. 5.9 cells were cultured with plate-coated anti-CD3 mAb (5 ug/ml) for 24 h, and cells recovered
were stained with propidium iodide (2 ttg/ml) to show dead cells.Figure4.
￿
Rescue ofproliferation ofclone 5.9 to IL2by accessory cells .
TheT cells (2 x 10 4/well) were cultured with IL2 (50 U/ml), given con-
centrations of plate-bound anti-CM mAb, in the presence (shaded ban)
or absence (solid bars) of mitomycin C-treated, T -depleted spleen cells
(105/well) for 48 h, and proliferation was determined by 13H]TdR incor-
poration . Proliferation of mitomycin C-treated, Tdepleted spleen cells is
always <1,000 cpm .
with plates coated with antiThy-1 mAb proliferate in response
to exogenous IIr2, while such proliferative responses were
significantly inhibited in the presence of plate-bound anti-
CD3 or antiTCR mAb . A similar level of cell death was
observed in all of five other Thl clones tested, but not in
any of the Th2 clones tested (data not shown) . Thus, the
TCR ligation, which induces clonal expansion ofcloned Thl
cells in the presence of accessory cells (data not shown), in-
duces cell death when presented without accessory cells.
Accessory Cells Prevent Induced Cell Death.
￿
The loss of
proliferation in response to IIr2 provides a second quantita-
tive assay for the death of Thl clones . To test if accessory
Specific cell death
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Figure 6.
￿
Inhibition of cell death by anti-IFN-y mAb . 5.9 cells (2 x
104/well) were cultured with plate-bound anti-CD3 mAb (5 hg/ml) in
the presence of anti-IFN-y and anti-IIT2mAbs (200 ug/ml), andcell death
was determined at 16 h by trypan blue exclusion.
cells could rescue the Thl clones from death inducedby anti-
CD3 mAb, we measured the proliferation of the Thl clone
5.9 to IIr2 in the presence or absence of anti-CD3 mAb and
T-depleted spleen adherent cells. As shown in Fig. 4, the
proliferative response of clone 5.9 to exogenous 1172 was in-
hibited by plate-coated anti-CD3 mAb, and the degree of
inhibition is proportional to the concentration of anti-CD3
mAb added . This inhibition is reversed by the addition of
spleen-adherent cells .
The Induction of Cell Death in Cloned TO Cells Requires
Production ofIFN-y. To analyze the mechanism of anti-
CD3/TCRinduced cell death, cyclosporin A (CsA) was added
to cultures of clone 5.9 cells . As seen in Fig. 5, CsA sig-
nificantly inhibits the death of cloned Thl cells induced by
anti-CD3 .
Because CsA inhibits cell death induced by anti-CD3, a
Figure 5.
￿
Inhibition ofanti-CD3-induced cell
death by C&A and restoration of cell death by
rIFN-y . 5.9 cells (2 x 104/well) were cultured,
with plate-bound anti-CD3mAb (5 Fog/ml) and
C&A (100 ng/ml) for 24 h, and cell death was de-
termined by trypan blue e=lusion. IFN-y (1,000
U/ml) was added at the beginning of culture.
Specific cell death of clone 5.9 is -0.4% when
treated with CsA (100 ng/ml) andIFN-y (1,000
U/ml) in the absence of anti-CD3 .possible role ofcytokines in the induced deathofcloned Thl
cellswas examined. As we can detect a large amount of IL-2
(100 U/ml) and IFN-y (1,000 U/ml) in anti-CD3-induced
clone 5.9 supernatants, we tested the ability of anti-IL-2 and
anti-IFN-y mAbs to inhibit cell death. As shown in Fig. 6,
anti-IFN-y mAb inhibits cell death induced by anti-CD3,
whileanti-IL2 mAb has no effect. Similarly, anti-IFN-y mAb
reversed the inhibition of IL2 responsiveness induced by anti-
CD3 mAb (datanot shown). The role ofIFN-y was confirmed
by reconstitution experiments, which demonstrate that IFN-'y
restored cell death that had been inhibited by CsA (Fig. 5),
and also reconstituted inhibition ofIL2 responsiveness (data
not shown). Thus, IFN-y appears to be required for this re-
sponse. Its removal by anti-IFN-y prevents cell death, and
its provision to Thl cellsblocked by CSA restores cell death.
However, IFN-y alone is not sufficient for cell death, since
IFN-y treatment of unstimulated clone 5.9 cells is not cyto-
toxic, and IFN-y is produced in large amounts when clone
5.9 is stimulated by anti-TCR mAb and accessory cells, which
does not cause cell death. Further experiments show that the
missing factor is not a cytokine, as anti-CD3-stimulated 5.9
supernatant can induce death of CsA-treated 5.9 cells only
in the presence of crosslinked anti-CD3 (data not shown).
In summary, our results demonstrate that TCR crosslinking
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